Baxter International (BAX) Capital Expenditures (2009 - 2026)

Baxter International (BAX) has 18 years of Capital Expenditures data on file, last reported at $137.0 million in Q1 2026.

• Quarterly Capital Expenditures rose 12.3% year-over-year to $137.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $528.0 million (up 15.28% YoY) and the FY2025 annual result came in at $513.0 million, up 15.02% from the prior year.
• Capital Expenditures fell to $137.0 million in Q1 2026 per BAX's latest filing, from $140.0 million in the prior quarter.
• Across five years, Capital Expenditures topped out at $165.0 million in Q1 2023 and bottomed at -$61.0 million in Q4 2022.
• The 5-year median for Capital Expenditures is $134.0 million (2024), against an average of $112.1 million.
• The widest annual swing landed in 2022, when Capital Expenditures plunged 133.33%; it then jumped 1016.67% in 2024.
• Tracing BAX's Capital Expenditures over 5 years: stood at -$61.0 million in 2022, then jumped by 250.82% to $92.0 million in 2023, then soared by 43.48% to $132.0 million in 2024, then rose by 6.06% to $140.0 million in 2025, then decreased by 2.14% to $137.0 million in 2026.
• Per Business Quant, the three latest BAX Capital Expenditures figures stand at $137.0 million (Q1 2026), $140.0 million (Q4 2025), and $111.0 million (Q3 2025).

Peer Comparison